KAT2B and cancer: PTEN and TP53 are known tumor suppressor proteins—impairing of KAT2B activity may contribute to genome instability; both oncogenic and tumor suppressive effects of EZH2 have been demonstrated in different cancer types and its expression is known to be regulated by miRNAs [33,34].